advertisement
Eye 144
Showing records 1 to 25 | Display all abstracts in Eye118510 Age related cerebrospinal fluid flow dynamics in the subarachnoid space of the optic nerve in patients with normal tension glaucoma, measured by diffusion weighted MRI
Berberat J
Eye 2024; 38: 2575-2580
116890 Visual field progression patterns in the ocular hypertension treatment study correspond to vulnerability regions of the disc
Leshno A
Eye 2024; 38: 1549-1555
118304 Evaluation of a telemedicine-enabled universal eye health delivery model in rural southern India
Joseph S
Eye 2024; 38: 1202-1207
117167 Comparison of intraocular pressure profiles during the water drinking test and the modified diurnal tension curve
Yap TE
Eye 2024; 38: 1567-1574
116945 Three-year clinical outcome of XEN45 Gel Stent implantation versus trabeculectomy in patients with open angle glaucoma
Rauchegger T
Eye 2024; 38: 1908-1916
117776 The value of virtual glaucoma clinics: a review
Mercer R
Eye 2024; 38: 1840-1844
116774 Evaluation of an offline, artificial intelligence system for referable glaucoma screening using a smartphone-based fundus camera: a prospective study
Rao DP
Eye 2024; 38: 1104-1111
118432 Comparing efficacy of charged-particle therapy with brachytherapy in treatment of uveal melanoma
Tseng YH
Eye 2024; 38: 1882-1890
116969 Glaucoma as a cause of optic nerve abnormalities on magnetic resonance imaging
Mosleh R
Eye 2024; 38: 1626-1632
118902 Sight impairment registration in Trinidad: trend in causes and population coverage in comparison to the National Eye Survey of Trinidad and Tobago
Ramsewak S
Eye 2024; 38: 2134-2142
117851 Diagnosing glaucoma in primary eye care and the role of Artificial Intelligence applications for reducing the prevalence of undetected glaucoma in Australia
Jan C
Eye 2024; 38: 2003-2013
116787 Short-term outcomes of Mitomycin-C augmented phaco-trabeculectomy using subconjunctival injections versus soaked sponges: a randomized controlled trial
Chakrabarty S
Eye 2024; 38: 1196-1201
118807 Programmed axon death: a promising target for treating retinal and optic nerve disorders
Loreto A
Eye 2024; 38: 1802-1809
116906 Mid-term real world outcomes of the Hydrus Microstent in open angle glaucoma
Kiramira D
Eye 2024; 38: 1454-1461
118484 Incidence of ocular pathology following bariatric surgery for with morbid obesity across a large United States National Database
Russell MW
Eye 2024; 38: 2603-2609
118227 Cyclodiode vs micropulse transscleral laser treatment
Kelada M
Eye 2024; 38: 1477-1484
116944 Dysphotopsia and location of laser iridotomy: a systematic review
Balas M
Eye 2024; 38: 1240-1245
118512 Developing ophthalmology in Cambodia
Mandal P
Eye 2024; 38: 1084-1090
117059 Correlation of contrast sensitivity with ganglion cell/inner plexiform layer thickness and damage location in glaucoma with varying severity
Pang R
Eye 2024; 38: 1308-1313
117411 Imaging of aqueous outflow in health and glaucoma. Justifying the re-direction of aqueous
Lusthaus JA
Eye 2024; 0:
118197 Quantitative evaluation of OCT angiography images in healthy and glaucomatous subjects through a novel approach: exploring inter-image variability
Cassottana P
Eye 2024; 38: 1903-1907
117083 Quantitative analysis of dynamic iris changes in primary angle-closure disease with long axial lengths: the Handan Eye Study
Wang J
Eye 2024; 38: 1362-1367
116895 Higher intraocular pressure is associated with slower axial growth in children with non-pathological high myopia
Yii FS
Eye 2024; 38: 1208-1214
117803 Global estimates on the number of people blind or visually impaired by glaucoma: A meta-analysis from 2000 to 2020
Vision Loss Expert Group of the Global Burden of Disease Study
Eye 2024; 38: 2036-2046
118961 Systematic review of clinical practice guidelines for the diagnosis and management of retinal vein occlusion
Galvez-Olortegui J
Eye 2024; 38: 1722-1733